FILAB supports you in your needs for particle analysis in injectables.
First of all, an injectable product is a drug in the form of a gel or solution that is injected into the body by the parenteral route, i.e. by intravenous, intramuscular, intradermal or subcutaneous injections. Injectable drugs are therefore administered with specific equipment such as syringes.
This type of administration allows an exact dosage of a product without digestive interference. In addition, the action of an injected drug is faster.
Why perform a particle analysis in an injectable?
Injectable products are subject to particular attention with regard to the risk of contamination. The objective is to guarantee safety throughout the manufacturing process by verifying the absence of undesirable particles in the injectable products. Indeed, it must be possible to detect the appearance of abnormal endogenous particles such as glass particles. The appearance of undesirable particles is a problem that can lead to the withdrawal of the injectable solution or the non-authorization of the marketing.
Therefore, the support of a laboratory competent in the analysis of particles in injectables is indispensable in the framework of a quality control or an injectable development process in the medical industry.
FILAB supports you in your needs for particle analysis in injectables
Through our three levels of services: analysis, expertise and R&D support, FILAB assists companies in the medical industry with their particle analysis needs in injectables. FILAB provides its clients with the know-how and experience of its team, as well as a 2100m² analytical park equipped with state-of-the-art equipment.
our technical means
Infrared coupled optical microscopy (µ-FTIR)
ICP technique (ICP/AES and ICP/MS)
Separative analytical techniques such as GC-MS or LC-MS
